Skip to main content

BBCI Looking for Scientific Assistant, Quality Manager, Scientific Officer

B.Pharmacy and two years Diploma in Medical Imaging Technology from State Board of Technical Education Or Any equivalent recognized Board, University. Dr. Bhubaneswar Borooah Cancer Institute
Crescent Formulations Hiring Marketing Manager
MBA in Marketing with strong science background. Experience in Pharma Marketing with team leadership role preferably neurology and psychiatry
Advertisement for Life Sciences candidates at BIRAC - Salary upto Rs. 4,20,000 per month
strong knowledge of vaccines, biotherapeutics and/or medical devices/diagnostics product development; BIRAC
National Institute of Immunology Openings for Life Sciences or Biotechnology
National Institute of Immunology require Biotechnology or Life Science candidate. experience in basic molecular biology, cloning, expression, and purification of recombinant proteins
Applications are invited for JRF at Institute of Nano Science and Technology
Post Graduate degree in Chemistry or Graduate, Post Graduate Degree in Professional Course selected through National Eligibility Tests – CSIR-UGC NET including lectureship Assistant Professorship or GATE. 
Interview for PG in Life Sciences candidates at PGIMER
Post Graduate Degree Life Science, including the integrated PG degree selected through any one of the following exams CSIR/UGC/GATE/ICMR
ANRF-Convergence Research Centres of Excellence for Pharmacy and Life Sciences
Anusandhan National Research Foundation aims to establish convergence research Centres of Excellence to undertake cutting edge, innovative and impactful research at the interface of Science, Technology, Humanities, Social Sciences and Society.
Require Pharmacovigilance Services Associate at Accenture - B.Pharm, M.Pharm Apply
In this role you are required to solve routine problems, largely through precedent and referral to general guidelines 
M.Pharm, MSc candidates hiring at Apitoria Pharma - Executive / Senior Executive Post
Responsible for LC-MS, MS method development, method validation and batch analysis. Impurity profiling for identification of unknown impurities in small molecules.
Walk in Drive for D.Pharm, B.Pharm, M.Pharm in Production and Quality at Granules India
Granules India is a vertically integrated, high-growth pharmaceutical company with 38 years of proven performance and increasing performance and increasing presence across the world.
Aculife Healthcare looking for Research Scientist / Executive - M.Pharm Apply
PHARMACY GRADUATE WITH 3 TO 7 YEARS OF EXPERIENCE IN FORMULATION DEVELOPMENT OF STERILE DOSAGE FORMS AS PER GUIDELINES OF US, EU, CANADA, BRAZIL AND ROW MARKET.
Hiring IPR Executive / Senior Executive at Apitoria Pharma - M.Pharm, MSc Apply
Candidate should have experience in the IP evaluation of APIs, Infringement analysis, FTO analysis and summary reports, patent searching, patent drafting, patent filing and patent prosecution.
Glenmark and AbbVie sign USD 700 million drug licensing agreement
AbbVie and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGIs lead investigational asset, ISB 2001, developed using IGIs proprietary BEAT protein platform, for oncology and autoimmune diseases
Ascentage Pharma Announces Its Novel Bcl-2 Inhibitor Lisaftoclax Approved by China NMPA, Ushering in a New Era for the Treatment of CLL/SLL

Ascentage Pharma a global biopharmaceutical company dedicated to addressing unmet medical needs in cancers, announced that its proprietary novel Bcl-2 selective inhibitor lisaftoclax (APG-2575) has been approved by China’s National Medical Products Administration (NMPA) for the treatment of adult patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) who have previously received at least one systemic therapy including Bruton’s tyrosine kinase (BTK) inhibitors, which makes lisaftoclax the first Bcl-2 inhibitor receiving conditional approval

Milestone Pharmaceuticals announces FDA acceptance of the Company’s Response to the CRL for CARDAMYST (etripamil) Nasal Spray

Milestone Pharmaceuticals Inc announced that the U.S. Food and Drug Administration (FDA) has accepted for review Milestone’s response to issues raised in the Complete Response Letter (CRL) for CARDAMYST™ (etripamil) nasal spray, an investigational, novel therapy for the treatment of patients with paroxysmal supraventricular tachycardia (PSVT). The FDA has assigned a new Prescription Drug User Fee Act (PDUFA) target action date of December 13, 2025.

Opportunity for B.Pharm, MSc as JRF in Amity Institute of Virology and Immunology
B.S. 4 years programme , BPharm, MBBS, Integrated BS-MS, MSc, BE, BTech or equivalent degree, with 55% marks and passing of NET, GATE test.
Ministry of Defence Hiring Pharmacists (04 posts)
B.Pharmacy / Diploma in Pharmacy and registered as Pharmacist under the Pharmacy Act 1948, Minimum 03 years Work Experience
Pharmacy Apprentice under the Ministry of Power at NHPC Limited
A Direct Benefit Transfer (DBT) amount of Rs. 4000 for Diploma Apprentices will be provided by Govt. of India under NATS scheme. The above stipend is inclusive of DBT amount wherever applicable.
Interview for B.Pharm, MSc as JRF at IIT Guwahati
Post Graduate degree in basic science M.Sc./ BE/ B.Tech/ B.VSc/ B.Pharm or Graduate / Post Graduate Degree in Professional Course.
Invites applications for Post of Pharmacist at ECHS Polyclinics Patiala and Samana
Approved Diploma in Pharmacy from Recognized by the Pharmacy Council of India and Registered as Pharmacist under the Pharmacy Act 1948.
Subscribe to